Genetic of SportS Induced Endofibrotic Remodeling

Genetic Syndrome Clinical Trial

— GOSSER  

Official title:

Endofibrose Vasculaire et génétique

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02704260
• Other study ID #: 2015-A00441-48
• Status: Completed
• Phase: N/A
• First received: February 23, 2016
• Last updated: October 30, 2017
• Start date: March 2, 2016
• Est. completion date: September 2, 2016

Study information

• Verified date: December 2016
• Source: University Hospital, Angers
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

search for a genetic cause of vascular endofibrose

Description:

Perform a DNA analysis to mark the existence of mutations in one or more genes encoding proteins involved in vascular remodeling high.

5 patients or relatives of patients topics

Recruitment information / eligibility

• Status: Completed
• Enrollment: 5
• Est. completion date: September 2, 2016
• Est. primary completion date: September 2, 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• High level reached Cyclists vascular endofibrose

• Cyclist high level and not sick with a brother or sister is senior cyclist reaches the vascular endofibrose.

Exclusion Criteria:

• not obtaining consent

Related Conditions & MeSH terms

• Genetic Syndrome

Intervention

Genetic:
• GENETIC ANALYSIS
prélevement blood to search for a genetic cause of vascular endofibrose. Search genetic mutations in 5 subjects.

Locations

Country	Name	City	State
France	University Hospital	Angers

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Angers

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Presence of mutations or nucleotides variations	DNA analysis and search for genetic mutations	1 hour